Clinical trial
Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma
NCT03015610 is registered in ClinicalTrials.gov with Jason Lang, M.D., M.P.H. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma
- Lead sponsor
- Jason Lang, M.D., M.P.H.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2017
- Completion date
- January 18, 2024
- Enrollment
- 41 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.